CCG Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-499
Closed -$256K 75
2022
Q4
$256K Sell
499
-29
-5% -$14.7K 0.14% 77
2022
Q3
$240K Sell
528
-15
-3% -$7.18K 0.15% 75
2022
Q2
$262K Buy
543
+11
+2% +$5.44K 0.15% 77
2022
Q1
$261K Sell
532
-6
-1% -$2.74K 0.13% 97
2021
Q4
$249K Hold
538
0.13% 74
2021
Q3
$201K Hold
538
0.12% 99
2021
Q2
$205K Buy
+538
New +$206K 0.16% 80

Other funds holding ELV

CCG Wealth Management's ELV Position: Q1 2023 in Review

CCG Wealth Management sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 499 shares — an estimated $256K sold.

CCG Wealth Management first reported a position in ELV in Q2 2021 and held it in 7 quarters. The position peaked at $262K in Q2 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • CCG Wealth Management reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • CCG Wealth Management sold 499 Elevance Health shares in Q1 2023, an estimated $256K.
  • CCG Wealth Management first reported a position in Elevance Health in Q2 2021 and held it in 7 quarters.
  • CCG Wealth Management's Elevance Health position peaked at $262K in Q2 2022.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on CCG Wealth Management's 13F filing for Q1 2023, filed 12 Apr 2023.